Interleukin 1α increases serum leptin concentrations in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 3084-3086

  Janik, John E ^a   Curti, Brendan D ^a   Considine, Robert V ^b   Rager, Helen C ^c   Powers, Geraldine C ^c   Alvord, W Gregory ^c   Smith II, John W ^d   Gause, Barry L ^a   Kopp, William C ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c SAIC FREDERICK INC   (United States)

^d PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GENE PRODUCT; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; LEPTIN; RECOMBINANT INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVANCED CANCER; AGED; ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; AGED; APPETITE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERLEUKIN-1; LEPTIN; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PROTEINS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TIME FACTORS;

ANIMALIA; CRICETINAE;

EID: 0030959788     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.3084     Document Type: Article

References (29)

1. Schwartz MW, Dallman MF, Woods SC. 1995 Hypothalamic response to starvation: implications for the study of wasting disorders. Am J Physiol. 38:R949-R957.
2. Buetler B, Cerami A. 1987 Cachectin: more than a tumor necrosis factor. N Engl J Med. 316:379-385.
3. Chrousos GP. 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 332:1351-1362.
4. Gaillard RC. 1994 Neuroendocrine-immune system interactions. The immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 5:303-309.
5. Grunfeld C, Feingold K. 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 327:329-337.
6. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1:1155-1161.
7. Spina M, Merlo-Pich E, Chan RKW, et al. 1996 Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1561-1564.
8. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292-295.
9. Gerald C, Walker MW, Criscione L, et al. 1996 A receptor subtype involved in neuropeptide-Y-induced food-intake. Nature. 382:168-171.
10. Erickson JC, Clegg KE, Palmiter RD. 1996 Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide-Y. Nature. 381:415-418.
11. Considine RV, Caro JF. 1996 Leptin in humans - current progress and future-directions. Clin Chem. 42:843-844.
12. Zhang YR, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-431.
13. Lee G, Proenca R, Montez JM, et al. 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632-635.
14. Weigle DS, Bukowski TR, Foster DC, et al. 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 96:2065-2070.
15. Campfield LA, Smith FJ, Gulsez Y, Devos R, Burn P. 1995 Mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-549.
16. Pelleymounler MA, Cullen MJ, Baker MB, et al. 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
17. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543-546.
18. Grunfeld C, Zhao C, Fuller J, et al. 1996 Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 97:2152-2157.
19. Sarraf P, Frederich RC, Turner EW, et al. 1997 Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 185:171-175.
20. Smith II JW, Longo DL, Alvord WG, et al. 1993 The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin. N Engl J Med. 328:756-761.
21. Grunfeld C, Pang M, Shigenaga JK, et al. 1996 Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 81:4342-4346.
22. Suda T, Tozawa F, Ushiyama T, Sumitomo T, Yamada M, Demura H. 1990 Interleukin-1 stimulates corticotropin-releasing factor gene expression in rat hypothalamus. Endocrinology. 126:1223-1228.
23. Uehara A, Sekiya C, Takasugi Y, Namiki M, Arimura A. 1989 Anorexia induced by interleukin 1:involvement of corticotropin-releasing factor. Am J Physiol. 257:R613-R617.
24. Berkenbosch F, Van Oers, Del Rey A, Tilders F, Besedovsky H. 1987 Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 238:524-526.
25. Considine RV, Nyce MR, Kolaczynski JW, et al. 1996 Insulin inhibits the dexamethasone stimulated increase in OB expression in human adipocytes. Diabetes. 45:S2:630.
26. Slieker LJ, Sloop KW, Surface PL, et al. 1996 Regulation of expression of OB messenger-RNA and protein by glucocorticoids and cAMP. J Biol Chem. 271:5301-5304.
27. Larsson H, Ahren B. 1996 Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab. 81:4428-4432.
28. Papaspyrou-Rou S, Schneider SH, Petersen RN, Fried SK. 1997 Dexamethasone increases leptin expression in humons in vivo. J Clin Endocrinol Metab. 82:1635-1637.
29. Curti BD, Urba WJ, Longo DL, et al. 1996 Endocrine effects of IL-1α and β administered in a phase I trial to patients with advanced cancer. J Immunother. 19:142-148.